Edition:
United Kingdom

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

37.43USD
5:36pm GMT
Change (% chg)

$-0.08 (-0.21%)
Prev Close
$37.51
Open
$37.84
Day's High
$38.15
Day's Low
$37.26
Volume
24,302
Avg. Vol
46,468
52-wk High
$42.00
52-wk Low
$19.34

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.43 -1.039
Jun '17 0.44 -0.945
Mar '17 0.37 -0.775
FY 2016 Dec '16 1.04 -0.535
Sep '16 1.17 -0.724
Jun '16 1.14 -0.528
Mar '16 1.26 -0.817
FY 2015 Dec '15 1.98 -0.477
Sep '15 2.12 -0.298
Jun '15 1.94 -0.627
Mar '15 2.08 0.058
 
*Note: Units in Millions ofEuro
**Note: Units in Euro

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Dec-17 6 0.33 0.51 0.00 0.57
Quarter Ending Mar-18 2 0.75 1.10 0.40 --
Year Ending Dec-17 6 1.73 2.00 1.50 2.23
Year Ending Dec-18 6 2.04 4.25 0.80 2.34
Earnings (per share)
Quarter Ending Dec-17 5 -0.79 -0.60 -0.94 -0.44
Quarter Ending Mar-18 3 -0.74 -0.62 -0.89 --
Year Ending Dec-17 6 -3.47 -2.87 -3.66 -1.98
Year Ending Dec-18 6 -3.12 -2.48 -3.53 -2.41
Sales and Profit Figures in Euro (EUR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 88.65 32.93
P/E High - Last 5 Yrs. -- 290.75 45.62
P/E Low - Last 5 Yrs. -- 93.66 24.34
Beta -- 0.85 0.88
Price to Sales (TTM) 367.07 100.67 5.40
Price to Book (MRQ) 7.85 13.50 5.38
Price to Tangible Book (MRQ) 9.04 13.43 6.78
Price to Cash Flow (TTM) -- 76.23 23.45
% Owned Institutions 64.55 6.25 1.40

Dividends

  Company industry sector
Dividend Yield -- 0.29 1.50
Dividend Yield - 5 Year Avg -- 0.28 1.52
Dividend 5 Year Growth Rate -- 1.88 5.17
Payout Ratio(TTM) -- 17.26 43.76

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -60.92 433.84 9.00
Sales (TTM) vs TTM 1 Yr. Ago -53.33 75.03 5.38
Sales - 5 Yr. Growth Rate -- 33.47 10.33
EPS (MRQ) vs Qtr. 1 Yr. Ago -79.01 30.81 19.67
EPS (TTM) vs TTM 1 Yr. Ago -40.57 -- --
EPS - 5 Yr. Growth Rate -- 43.17 10.79
Capital Spending - 5 Yr. Growth Rate -- 40.71 15.25

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.18
Current Ratio (MRQ) 8.54 5.36 2.98
LT Debt to Equity (MRQ) 0.00 18.92 11.56
Total Debt to Equity (MRQ) 0.00 20.59 15.81
Interest Coverage (TTM) -- -112.49 33.29

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 38.73 54.83
Gross Margin - 5 Yr. Avg. -- 51.18 52.40
EBITD Margin (TTM) -2,898.05 -- --
EBITD - 5 Yr. Avg -- -261.11 15.24
Operating Margin (TTM) -2,920.87 -556.64 7.76
Operating Margin - 5 Yr. Avg. -- -279.29 10.75
Pre-Tax Margin (TTM) -2,993.16 -529.88 8.57
Pre-Tax Margin - 5 Yr. Avg. -- -279.02 11.17
Net Profit Margin (TTM) -2,990.32 -531.33 4.88
Net Profit Margin - 5 Yr. Avg. -- -282.20 7.47
Effective Tax Rate (TTM) -- 23.72 23.11
Effective Tax Rate - 5 Yr. Avg. -- 19.13 24.00

Efficiency

  Company industry sector
Revenue/Employee (TTM) 35,176 25,314,503 864,673,366
Net Income/Employee (TTM) -1,051,866 3,332,048 101,717,513
Receivable Turnover (TTM) 7.19 21.54 5.76
Inventory Turnover (TTM) -- 2.01 3.34
Asset Turnover (TTM) 0.02 0.37 0.93

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -73.87 -0.78 11.00
Return on Assets - 5 Yr. Avg. -- -0.26 12.43
Return on Investment (TTM) -83.31 2.35 14.46
Return on Investment - 5 Yr. Avg. -- 2.98 16.28
Return on Equity (TTM) -83.31 2.95 16.05
Return on Equity - 5 Yr. Avg. -- 6.40 17.51
  1 Year 3 Year 5 Year
Sales % -43.26 -39.12 --
EPS (TTM) % -86.17 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Ascendis Pharma A/S

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week 25.98 21.63 88 54
13 Week 27.10 20.91 83 61
26 Week 30.62 20.69 80 69
52 Week 78.77 51.52 86 46
YTD 76.83 55.29 84 50
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 79.88%
# of Holders: 72
Total Shares Held: 29,049,472
3 Mo. Net Change: 5,561,623
# New Positions: 31
# Closed Positions: 2
# Increased Positions: 55
# Reduced Positions: 12
# Net Buyers: 43
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.